ArticleJournal of medical case reports2026

NTRK fusion in metastatic castration-resistant prostate cancer treated with entrectinib: a case report.

Shuichi Tatarano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.